India · Delayed Price · Currency is INR Suven Life Sciences Statistics
Total Valuation
NSE:SUVEN has a market cap or net worth of INR 63.21 billion. The enterprise value is 62.61 billion.
| Market Cap | 63.21B |
| Enterprise Value | 62.61B |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 218.07M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.45% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 61.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 949.68 |
| PB Ratio | 57.47 |
| P/TBV Ratio | 57.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -38.95 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -32.71 |
Financial Position
The company has a current ratio of 3.21
| Current Ratio | 3.21 |
| Quick Ratio | 2.62 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,682.30 |
Financial Efficiency
Return on equity (ROE) is -84.60% and return on invested capital (ROIC) is -56.34%.
| Return on Equity (ROE) | -84.60% |
| Return on Assets (ROA) | -51.06% |
| Return on Invested Capital (ROIC) | -56.34% |
| Return on Capital Employed (ROCE) | -153.63% |
| Revenue Per Employee | 472,043 |
| Profits Per Employee | -11.40M |
| Employee Count | 141 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +115.00% in the last 52 weeks. The beta is 0.82, so NSE:SUVEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +115.00% |
| 50-Day Moving Average | 237.38 |
| 200-Day Moving Average | 155.18 |
| Relative Strength Index (RSI) | 70.02 |
| Average Volume (20 Days) | 217,093 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUVEN had revenue of INR 66.56 million and -1.61 billion in losses. Loss per share was -7.37.
| Revenue | 66.56M |
| Gross Profit | 66.56M |
| Operating Income | -1.72B |
| Pretax Income | -1.61B |
| Net Income | -1.61B |
| EBITDA | -1.66B |
| EBIT | -1.72B |
| Loss Per Share | -7.37 |
Balance Sheet
The company has 600.05 million in cash and n/a in debt, giving a net cash position of 600.05 million.
| Cash & Cash Equivalents | 600.05M |
| Total Debt | n/a |
| Net Cash | 600.05M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.10B |
| Book Value Per Share | 5.06 |
| Working Capital | 519.86M |
Cash Flow
In the last 12 months, operating cash flow was -1.54 billion and capital expenditures -372.76 million, giving a free cash flow of -1.91 billion.
| Operating Cash Flow | -1.54B |
| Capital Expenditures | -372.76M |
| Free Cash Flow | -1.91B |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,578.13% |
| Pretax Margin | -2,415.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NSE:SUVEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.54% |
| FCF Yield | -3.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |